Connect with us

Hi, what are you looking for?

Sunday, Jun 1, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "major depressive disorder"

Gilgamesh's psychedelic drug demonstrates remarkable efficacy for treating depression

Gilgamesh's psychedelic drug demonstrates remarkable efficacy for treating depression

Psychedelics

Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression

GM-2505 is a compound with faster onset and shorter duration than psilocybin

Rowan Dunne2 days ago

Cybin receives FDA approval for new in-human clinical trial

Cybin receives FDA approval for new in-human clinical trial

Alternative Energy

Cybin receives FDA approval for new in-human clinical trial

Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly

Rowan DunneJune 28, 2022

Field Trip white paper makes strong health and business case for ketamine therapy

Field Trip white paper makes strong health and business case for ketamine therapy

Analysis

Field Trip white paper makes strong health and business case for ketamine therapy

With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle...

Natalia Buendia CalvilloFebruary 9, 2021

More Posts